123 related articles for article (PubMed ID: 35354139)
1. Metabolic Syndrome Is Associated with Impaired Survival after Surgery for Pancreatic Neuroendocrine Tumors.
Awwad F; Ozga AK; Amin T; Schlueter C; Kailani S; Perez D; Wolter S; Sauter G; Izbicki J; Lohse AW; Schrader J
Neuroendocrinology; 2022; 112(12):1225-1236. PubMed ID: 35354139
[TBL] [Abstract][Full Text] [Related]
2. Predicting Progression, Recurrence, and Survival in Pancreatic Neuroendocrine Tumors: A Single Center Analysis of 174 Patients.
Krogh S; Grønbæk H; Knudsen AR; Kissmeyer-Nielsen P; Hummelshøj NE; Dam G
Front Endocrinol (Lausanne); 2022; 13():925632. PubMed ID: 35837305
[TBL] [Abstract][Full Text] [Related]
3. Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors.
Sun Y; Wang Y; Li R; Kang G; Zhang M; Chen X; Jin M; Liu Y; He Y; Zhu X; Kang Q; Zhou F; Yu Q
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101432. PubMed ID: 32386797
[TBL] [Abstract][Full Text] [Related]
4. A single-center experience with pancreatic cystic neuroendocrine tumors.
Khalil A; Ewald J; Marchese U; Autret A; Garnier J; Niccoli P; Piana G; Poizat F; Giovannini M; Delpero JR; Turrini O
World J Surg Oncol; 2020 Aug; 18(1):208. PubMed ID: 32799893
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.
Titan AL; Norton JA; Fisher AT; Foster DS; Harris EJ; Worhunsky DJ; Worth PJ; Dua MM; Visser BC; Poultsides GA; Longaker MT; Jensen RT
JAMA Netw Open; 2020 Nov; 3(11):e2024318. PubMed ID: 33146734
[TBL] [Abstract][Full Text] [Related]
6. A preoperative computed tomography radiomics model to predict disease-free survival in patients with pancreatic neuroendocrine tumors.
Homps M; Soyer P; Coriat R; Dermine S; Pellat A; Fuks D; Marchese U; Terris B; Groussin L; Dohan A; Barat M
Eur J Endocrinol; 2023 Oct; 189(4):476-484. PubMed ID: 37787635
[TBL] [Abstract][Full Text] [Related]
7. Observational study of surgical resection in small non-functional pancreatic neuroendocrine tumors: AS SEER-based study.
Lin J; Huang H
Sci Rep; 2023 Aug; 13(1):12824. PubMed ID: 37550460
[TBL] [Abstract][Full Text] [Related]
8. MRI-based nomogram estimates the risk of recurrence of primary nonmetastatic pancreatic neuroendocrine tumors after curative resection.
Sun HT; Zhang SL; Liu K; Zhou JJ; Wang XX; Shen TT; Song XH; Guo YL; Wang XL
J Magn Reson Imaging; 2019 Aug; 50(2):397-409. PubMed ID: 30589158
[TBL] [Abstract][Full Text] [Related]
9. Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors.
Makris EA; Cannon JGD; Norton JA; Lopez-Aguiar AG; Dillhoff M; Beal E; Idrees K; Smith PM; Rocha FG; Kanji Z; Cho C; Beems M; Weber S; Fisher A; Krasnick BA; Fields RC; Maithel SK; Poultsides GA
Ann Surg Oncol; 2023 Apr; 30(4):2424-2430. PubMed ID: 36434481
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features and long-term prognosis of purely cystic pancreatic neuroendocrine tumors: A single-center experience.
Ren SJ; Wang X; Ke NW; Tan QQ; Yang F; Yao WQ; Tan CL; Liu XB
Asian J Surg; 2023 Feb; 46(2):774-779. PubMed ID: 35850904
[TBL] [Abstract][Full Text] [Related]
11. Preoperative acute pancreatitis and hyperenzymemia are associated with poor prognosis in patients with nonfunctional pancreatic neuroendocrine tumors.
Song H; Tan Q; Yuan Y; Liu X; Chen Y; Wang X
J Surg Oncol; 2023 Jun; 127(7):1135-1142. PubMed ID: 36912877
[TBL] [Abstract][Full Text] [Related]
12. International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine Tumors.
Heidsma CM; van Roessel S; van Dieren S; Engelsman AF; Strobel O; Buechler MW; Schimmack S; Perinel J; Adham M; Deshpande V; Kjaer J; Norlen O; Gill AJ; Samra JS; Mittal A; Hoogwater FJH; Primavesi F; Stättner S; Besselink MG; van Eijck CHJ; Nieveen van Dijkum EJM
Neuroendocrinology; 2022; 112(6):571-579. PubMed ID: 34343138
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of the preoperative main pancreatic duct dilation and neutrophil-to-lymphocyte ratio in pancreatic neuroendocrine tumors (PNETs) of the head after curative resection.
Zhou B; Zhan C; Xiang J; Ding Y; Yan S
BMC Endocr Disord; 2019 Nov; 19(1):123. PubMed ID: 31718651
[TBL] [Abstract][Full Text] [Related]
14. Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis.
Gaitanidis A; Patel D; Nilubol N; Tirosh A; Sadowski S; Kebebew E
Ann Surg Oncol; 2018 Jan; 25(1):122-130. PubMed ID: 29134377
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes of Surgical Management of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases.
Partelli S; Inama M; Rinke A; Begum N; Valente R; Fendrich V; Tamburrino D; Keck T; Caplin ME; Bartsch D; Thirlwell C; Fusai G; Falconi M
Neuroendocrinology; 2015; 102(1-2):68-76. PubMed ID: 26043944
[TBL] [Abstract][Full Text] [Related]
16. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
[TBL] [Abstract][Full Text] [Related]
17. Recurrence and outcomes of non-functional pancreatic neuroendocrine tumours post-resection: an Australian retrospective, multicentre cohort study.
Lim S; Chong L; Peeroo S; Onasanya O; He E; Banting S; Croagh D
ANZ J Surg; 2023 Jan; 93(1-2):160-165. PubMed ID: 36562118
[TBL] [Abstract][Full Text] [Related]
18. Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors.
Tan QQ; Wang X; Yang L; Chen YH; Tan CL; Zhu XM; Ke NW; Liu XB
Medicine (Baltimore); 2020 Jun; 99(24):e20324. PubMed ID: 32541455
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
[TBL] [Abstract][Full Text] [Related]
20. Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors.
Zhang Z; Wang F; Li Z; Ye Z; Zhuo Q; Xu W; Liu W; Liu M; Fan G; Qin Y; Zhang Y; Chen X; Yu X; Xu X; Ji S
BMC Surg; 2022 May; 22(1):160. PubMed ID: 35538535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
